Article
Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology - 1 Dec 2012
Hudson Brian D, Christiansen Elisabeth, Tikhonova Irina G, Grundmann Manuel, Kostenis Evi, Adams David R, Ulven Trond, Milligan Graeme
Abstract excerpt
When it is difficult to develop selective ligands within a family of related G-protein-coupled receptors (GPCRs), chemically engineered receptors activated solely by synthetic ligands (RASSLs) are useful alternatives for probing receptor function. In the present work, we explored whether a RASSL of the free fatty acid receptor 2 (FFA2) could be developed on the basis of pharmacological variation between species...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
